Cargando…

Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer

OBJECTIVES: Sentinel lymph node (SLN) sampling has become a standard practice in managing early-stage breast cancer. Lymphoscintigraphy is one of the major methods used. The radioactive tracer used in Taiwan is Tc-99m phytate. However, this agent is not commonly used around the world and the optimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Ching-Chun, Chen, Yu-Hung, Liu, Shu-Hsin, Chen, Hwa-Tsung, Lee, Ming-Che
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559026/
https://www.ncbi.nlm.nih.gov/pubmed/31258292
http://dx.doi.org/10.4103/tcmj.tcmj_88_18
_version_ 1783425750535241728
author Ho, Ching-Chun
Chen, Yu-Hung
Liu, Shu-Hsin
Chen, Hwa-Tsung
Lee, Ming-Che
author_facet Ho, Ching-Chun
Chen, Yu-Hung
Liu, Shu-Hsin
Chen, Hwa-Tsung
Lee, Ming-Che
author_sort Ho, Ching-Chun
collection PubMed
description OBJECTIVES: Sentinel lymph node (SLN) sampling has become a standard practice in managing early-stage breast cancer. Lymphoscintigraphy is one of the major methods used. The radioactive tracer used in Taiwan is Tc-99m phytate. However, this agent is not commonly used around the world and the optimal imaging time has not been studied. Thus, we investigated the optimal imaging time of Tc-99m phytate lymphoscintigraphy for SLN mapping in patients with breast cancer. MATERIALS AND METHODS: We retrospectively reviewed SLN Tc-99m phytate lymphoscintigraphies in 135 patients with breast cancer between August 2013 and November 2017. The time for the first SLN to be visualized after radiotracer injection was recorded to determine the optimal imaging time. If no SLN was identified on imaging, the scan was continued to 60 min. We also recorded the presurgical technical and clinical factors to analyze the risk factors for nonvisualization of SLN. Each patient's postoperative axillary lymph node status was also recorded. RESULTS: Axillary SLNs were identified on imaging in 94.8% of the patients. All first SLNs presented within 30 min. In 6 of 7 patients with negative imaging, SLNs were identified during surgery using either blue dye or a hand-held gamma probe. Nonvisualization of SLNs on lymphoscintigraphy was significantly associated with a lower injection dose (1.0 mCi vs. 2.0 mCi), 4-injection protocol (compared to 2-injection), and injection around an outer upper quadrant tumor. In addition, patients with axillary lymph node metastasis had a higher percentage of SLN image mapping failure, with a marginally significant difference. CONCLUSION: Based on our study, 30 min after Tc-99m phytate injection is the optimal time for lymphoscintigraphy and delayed imaging beyond 30 min is not necessary. In addition, a lower injection dose, the 4-injection method, and an injection near the outer upper quadrant tumor should be avoided to minimize nonvisualization of SLNs.
format Online
Article
Text
id pubmed-6559026
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-65590262019-07-01 Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer Ho, Ching-Chun Chen, Yu-Hung Liu, Shu-Hsin Chen, Hwa-Tsung Lee, Ming-Che Tzu Chi Med J Original Article OBJECTIVES: Sentinel lymph node (SLN) sampling has become a standard practice in managing early-stage breast cancer. Lymphoscintigraphy is one of the major methods used. The radioactive tracer used in Taiwan is Tc-99m phytate. However, this agent is not commonly used around the world and the optimal imaging time has not been studied. Thus, we investigated the optimal imaging time of Tc-99m phytate lymphoscintigraphy for SLN mapping in patients with breast cancer. MATERIALS AND METHODS: We retrospectively reviewed SLN Tc-99m phytate lymphoscintigraphies in 135 patients with breast cancer between August 2013 and November 2017. The time for the first SLN to be visualized after radiotracer injection was recorded to determine the optimal imaging time. If no SLN was identified on imaging, the scan was continued to 60 min. We also recorded the presurgical technical and clinical factors to analyze the risk factors for nonvisualization of SLN. Each patient's postoperative axillary lymph node status was also recorded. RESULTS: Axillary SLNs were identified on imaging in 94.8% of the patients. All first SLNs presented within 30 min. In 6 of 7 patients with negative imaging, SLNs were identified during surgery using either blue dye or a hand-held gamma probe. Nonvisualization of SLNs on lymphoscintigraphy was significantly associated with a lower injection dose (1.0 mCi vs. 2.0 mCi), 4-injection protocol (compared to 2-injection), and injection around an outer upper quadrant tumor. In addition, patients with axillary lymph node metastasis had a higher percentage of SLN image mapping failure, with a marginally significant difference. CONCLUSION: Based on our study, 30 min after Tc-99m phytate injection is the optimal time for lymphoscintigraphy and delayed imaging beyond 30 min is not necessary. In addition, a lower injection dose, the 4-injection method, and an injection near the outer upper quadrant tumor should be avoided to minimize nonvisualization of SLNs. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6559026/ /pubmed/31258292 http://dx.doi.org/10.4103/tcmj.tcmj_88_18 Text en Copyright: © 2018 Tzu Chi Medical Journal http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Ho, Ching-Chun
Chen, Yu-Hung
Liu, Shu-Hsin
Chen, Hwa-Tsung
Lee, Ming-Che
Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer
title Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer
title_full Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer
title_fullStr Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer
title_full_unstemmed Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer
title_short Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer
title_sort optimal imaging time for tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559026/
https://www.ncbi.nlm.nih.gov/pubmed/31258292
http://dx.doi.org/10.4103/tcmj.tcmj_88_18
work_keys_str_mv AT hochingchun optimalimagingtimefortc99mphytatelymphoscintigraphyforsentinellymphnodemappinginpatientswithbreastcancer
AT chenyuhung optimalimagingtimefortc99mphytatelymphoscintigraphyforsentinellymphnodemappinginpatientswithbreastcancer
AT liushuhsin optimalimagingtimefortc99mphytatelymphoscintigraphyforsentinellymphnodemappinginpatientswithbreastcancer
AT chenhwatsung optimalimagingtimefortc99mphytatelymphoscintigraphyforsentinellymphnodemappinginpatientswithbreastcancer
AT leemingche optimalimagingtimefortc99mphytatelymphoscintigraphyforsentinellymphnodemappinginpatientswithbreastcancer